Yoshikazu Takada

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 15

Top Venues

Cells

Life science alliance

Biomolecules

PloS one

uc davis school of medicine

This page only lists publications with an associated author ORCID identifier.

Affiliation History

uc davis school of medicine Sep 01 2003

United States

professor :: dermatology

Publications

Chih-Chieh Chang, Yoko K Takada, Chao-Wen Cheng, Yukina Maekawa, Seiji Mori, Yoshikazu Takada
FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist. Cells 13 (4) (2024)
Yoko K Takada, Xuesong Wu, David Wei, Samuel Hwang, Yoshikazu Takada
FGF1 Suppresses Allosteric Activation of β3 Integrins by FGF2: A Potential Mechanism of Anti-Inflammatory and Anti-Thrombotic Action of FGF1. Biomolecules 14 (8) (2024)
Chih-Chieh Chang, Yoko K Takada, Chao-Wen Cheng, Yukina Maekawa, Seiji Mori, Yoshikazu Takada
FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist. Cells 13 (4) (2024)
Chih-Chieh Chang, Yoko K Takada, Chao-Wen Cheng, Yukina Maekawa, Seiji Mori, Yoshikazu Takada
FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist. Cells 13 (4) (2024)
Chih-Chieh Chang, Yoko K Takada, Chao-Wen Cheng, Yukina Maekawa, Seiji Mori, Yoshikazu Takada
FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist. Cells 13 (4) (2024)
Chih-Chieh Chang, Yoko K Takada, Chao-Wen Cheng, Yukina Maekawa, Seiji Mori, Yoshikazu Takada
FGF9, a Potent Mitogen, Is a New Ligand for Integrin αvβ3, and the FGF9 Mutant Defective in Integrin Binding Acts as an Antagonist. Cells 13 (4) (2024)
Yoko K Takada, Xuesong Wu, David Wei, Samuel Hwang, Yoshikazu Takada
FGF1 Suppresses Allosteric Activation of β3 Integrins by FGF2: A Potential Mechanism of Anti-Inflammatory and Anti-Thrombotic Action of FGF1. Biomolecules 14 (8) (2024)
Yoko K Takada, Scott I Simon, Yoshikazu Takada
The C-type lectin domain of CD62P (P-selectin) functions as an integrin ligand. Life science alliance 6 (7) (2023)
Yoko K Takada, Scott I Simon, Yoshikazu Takada
The C-type lectin domain of CD62P (P-selectin) functions as an integrin ligand. Life science alliance 6 (7) (2023)
Yoko K Takada, Michiko Shimoda, Yoshikazu Takada
CD40L Activates Platelet Integrin αIIbβ3 by Binding to the Allosteric Site (Site 2) in a KGD-Independent Manner and HIGM1 Mutations Are Clustered in the Integrin-Binding Sites of CD40L. Cells 12 (15) (2023)
Yoko K Takada, Scott I Simon, Yoshikazu Takada
The C-type lectin domain of CD62P (P-selectin) functions as an integrin ligand. Life science alliance 6 (7) (2023)
Yoko K Takada, Scott I Simon, Yoshikazu Takada
The C-type lectin domain of CD62P (P-selectin) functions as an integrin ligand. Life science alliance 6 (7) (2023)
Yoshikazu Takada, Masaaki Fujita, Yoko K Takada
Virtual Screening of Protein Data Bank via Docking Simulation Identified the Role of Integrins in Growth Factor Signaling, the Allosteric Activation of Integrins, and P-Selectin as a New Integrin Ligand. Cells 12 (18) (2023)
Yoko K Takada, Scott I Simon, Yoshikazu Takada
The C-type lectin domain of CD62P (P-selectin) functions as an integrin ligand. Life science alliance 6 (7) (2023)
Dora Maria Cedano Prieto, Yushen Cheng, Chih-Chieh Chang, Jessica Yu, Yoko K Takada, Yoshikazu Takada
Direct integrin binding to insulin-like growth factor-2 through the C-domain is required for insulin-like growth factor receptor type 1 (IGF1R) signaling. PloS one 12 (9) (2017)

Yoshikazu Takada.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yoshikazu Takada